Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2

被引：45

作者：

Chen, Chuan ^{[1
]}

Cao, Mengmeng ^{[1
]}

Zhu, Siyu ^{[1
]}

Wang, Cuicui ^{[1
]}

Liang, Fan ^{[1
]}

Yan, Leilei ^{[1
]}

Luo, Duqiang ^{[1
]}

机构：

[1] Hebei Univ, Minist Educ, Key Lab Med Chem & Mol Diag, Coll Life Sci, Baoding 071002, Hebei, Peoples R China

来源：

SCIENTIFIC REPORTS | 2015年 / 5卷

基金：

中国国家自然科学基金;

关键词：

BREAST-CANCER; KINASE-ACTIVITY; ACTIVATION; GAB1; RAS; SRC; PTPN11; FAMILY; EXPRESSION; PAXILLIN;

D O I：

10.1038/srep17626

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Shp2 is a ubiquitously expressed protein tyrosine phosphatase (PTP) related to adult acute myelogenous leukemia and human solid tumors. In this report, we describe identification of a potent Shp2 inhibitor, Fumosorinone (Fumos) from entomogenous fungi, which shows selective inhibition of Shp2 over other tested PTPs. Using a surface plasmon resonance analysis, we further confirmed the physical interaction between Shp2 and Fumos. Fumos inhibits Shp2-dependent activation of the Ras/ERK signal pathway downstream of EGFR, and interrupts EGF-induced Gab1-Shp2 association. As expected, Fumos shows little effects on the Shp2-independent ERK1/2 activation induced by PMA or oncogenic Ras. Furthermore, Fumos down-regulates Src activation, inhibits phosphorylation of Paxillin and prevents tumor cell invasion. These results suggest that Fumos can inhibit Shp2-dependent cell signaling in human cells and has a potential for treatment of Shp2-associated diseases.

引用

页数：13

共 58 条

[31] Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors [J].

Miyamoto, D. ;

Miyamoto, M. ;

Takahashi, A. ;

Yomogita, Y. ;

Higashi, H. ;

Kondo, S. ;

Hatakeyama, M. .

ONCOGENE, 2008, 27 (25) :3508-3515

[32] The role of Shp2 (PTPN11) in cancer [J].

Mohi, M. Golam ;

Neel, Benjamin G. .

CURRENT OPINION IN GENETICS & DEVELOPMENT, 2007, 17 (01) :23-30

[33] A novel role for Gab1 and SHP2 in epidermal growth factor-induced ras activation [J].

Montagner, A ;

Yart, A ;

Dance, M ;

Perret, B ;

Salles, JP ;

Raynal, P .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (07) :5350-5360

[34] The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling [J].

Neel, BG ;

Gu, HH ;

Pao, L .

TRENDS IN BIOCHEMICAL SCIENCES, 2003, 28 (06) :284-293

[35] Protein tyrosine phosphatases as novel targets in breast cancer therapy [J].

Nunes-Xavier, Caroline E. ;

Martin-Perez, Jorge ;

Elson, Ari ;

Pulido, Rafael .

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2013, 1836 (02) :211-226

[36] Protein-tyrosine phosphatases and cancer [J].

Östman, A ;

Hellberg, C ;

Böhmer, FD .

NATURE REVIEWS CANCER, 2006, 6 (04) :307-320

[37]

POWIS G, 1994, CANCER RES, V54, P2419

[38] Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor [J].

Ren, Y ;

Meng, SS ;

Mei, L ;

Zhao, ZJ ;

Jove, R ;

Wu, J .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (09) :8497-8505

[39] Tyrosine phosphatase SHP2 increases cell motility in triple-negative breast cancer through the activation of SRC-family kinases [J].

Sausgruber, N. ;

Coissieux, M-M ;

Britschgi, A. ;

Wyckoff, J. ;

Aceto, N. ;

Leroy, C. ;

Stadler, M. B. ;

Voshol, H. ;

Bonenfant, D. ;

Bentires-Alj, M. .

ONCOGENE, 2015, 34 (17) :2272-2278

[40] Paxillin Regulates Androgen- and Epidermal Growth Factor-induced MAPK Signaling and Cell Proliferation in Prostate Cancer Cells [J].

Sen, Aritro ;

O'Malley, Katherine ;

Wang, Zhou ;

Raj, Ganesh V. ;

DeFranco, Donald B. ;

Hammes, Stephen R. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (37) :28787-28795

← 1 2 3 4 5 6 →